Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tempus AI
TEM
5
Broadcom
AVGO
No Data
Bright Minds Biosciences | 6-K: Report of foreign private issuer (related to financial reporting)
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
Crude Oil Down 2%; ISM Services PMI Surges In December
Baird Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating, Announces Target Price $142
Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session